Viewing Study NCT02716012

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:20 PM
Ignite Modification Date: 2026-03-01 @ 5:01 PM
Study NCT ID: NCT02716012
Status: UNKNOWN
Last Update Posted: 2025-03-10
First Post: 2016-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
Sponsor: Mina Alpha Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
None Liver Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Oligonucleotide View
None RNA View
None saRNA View
None Sorafenib View
None Myeloid View